Backed by Wellington, Sanofi Ventures and a division of J.P. Morgan, Korsana Therapeutics is studying a treatment originally developed by hub-and-spoke biotech Paragon Therapeutics.
Continue reading →
More than 10,000 people have enrolled in Nevada’s new public option health plans, which debuted last fall with the expectation that they would bring lower prices to the health insurance market. Those preliminary numbers from the open enrollment period that ended in January are less than a...
The Australian company will retain rights for an end-stage kidney disease indication currently being tested in a Phase 3 trial while Lilly explores other uses.
Continue reading →
Less than 36 hours before his wife was scheduled to undergo major surgery, New York Times personal finance columnist Ron Lieber got an unwelcome letter from his family’s insurance plan: It was denying prior authorization for the procedure. With no time to lodge an appeal, Lieber and his...
Initial plans call for reviving the original Fred Segal location on Melrose Avenue in Los Angeles into an “experiential destination.”
Continue reading →
Leveraging local teacher vacancy funds or federal grants are among options available, said speakers in a National Center for Grow Your Own webinar.
Continue reading →
David Schuler, executive director of AASA, The School Superintendents Association, said schools are in a “disruption phase” for technology.
Continue reading →
The TFI International fourth quarter 2025 earnings call took place in the middle of the first quarter of 2026, but the company’s two management representatives on the forum made it clear that the first three months of the year have not been going well for the trucking conglomerate. After posting...